GENERATION AND VALIDATION OF RAPID COMPUTATIONAL FILTERS FOR CYP2D6 AND CYP3A4
Open Access
- 1 September 2003
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 31 (9) , 1077-1080
- https://doi.org/10.1124/dmd.31.9.1077
Abstract
CYP2D6 and CYP3A4 represent two particularly important members of the cytochrome P450 enzyme family due to their involvement in the metabolism of many commercially available drugs. Avoiding potent inhibitory interactions with both of these enzymes is highly desirable in early drug discovery, long before entering clinical trials. Computational prediction of this liability as early as possible is desired. Using a commercially available data set of over 1750 molecules to train computer models that were generated with commercially available software enabled predictions of inhibition for CYP2D6 and CYP3A4, which were compared with empirical data. The results suggest that using a recursive partitioning (tree) technique with augmented atom descriptors enables a statistically significant rank ordering of test-set molecules (Spearman's ρ of 0.61 and 0.48 for CYP2D6 and CYP3A4, respectively), which represents an increased rate of identifying the best compounds when compared with the random rate. This approach represents a valuable computational filter in early drug discovery to identify compounds that may have P450 inhibition liabilities prior to molecule synthesis. Such computational filters offer a new approach in which lead optimization in silico can occur with virtual molecules simultaneously tested against multiple enzymes implicated in drug-drug interactions, with a resultant cost savings from a decreased level of molecule synthesis and in vitro screening.Keywords
This publication has 12 references indexed in Scilit:
- Optimizing Higher Throughput Methods to Assess Drug–Drug Interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 In Vitro Using a Single Point IC50SLAS Discovery, 2002
- Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and SubstratesMolecular Pharmacology, 2002
- Pharmacophore modeling of cytochromes P450Advanced Drug Delivery Reviews, 2002
- A neural network based virtual screening of cytochrome P450 3A4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2002
- In silico ADME/Tox: the state of the artJournal of Molecular Graphics and Modelling, 2002
- Mixture deconvolution and analysis of Ames mutagenicity dataChemometrics and Intelligent Laboratory Systems, 2002
- The in silico world of virtual librariesDrug Discovery Today, 2000
- Properties of cytochrome P450 isoenzymes and their substrates part 2: properties of cytochrome P450 substratesDrug Discovery Today, 1997
- Properties of cytochrome P450 isoenzymes and their substrates Part 1: active site characteristicsDrug Discovery Today, 1997
- Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450Analytical Biochemistry, 1997